These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8277407)

  • 21. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects.
    Mustafa AS
    Med Princ Pract; 2009; 18(5):385-92. PubMed ID: 19648762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
    Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
    Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CD4+T cells restricted by DQ not by DR support CD8+T cells to grow].
    Kamikawaji N
    Fukuoka Igaku Zasshi; 1990 Feb; 81(2):88-96. PubMed ID: 2328939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
    Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
    Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V.
    Huang SK; Zwollo P; Marsh DG
    Eur J Immunol; 1991 Jun; 21(6):1469-73. PubMed ID: 2044656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA antigens of insulin-dependent diabetics. I. PLT colonies detecting Dw10 and a new class II determinant distinct from HLA-D, DR, MB(DC), MT, and SB.
    Sheehy MJ; Quintieri FB; Yang SY; Alosco SM; Matsui Y; Yunis EJ; Gabbay KH
    Tissue Antigens; 1984 May; 23(5):290-300. PubMed ID: 6205468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased interleukin-2 responses to Fusobacterium nucleatum and Porphyromonas gingivalis in generalized aggressive periodontitis.
    Borch TS; Løbner M; Bendtzen K; Holmstrup P; Nielsen CH
    J Periodontol; 2009 May; 80(5):800-7. PubMed ID: 19405834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periodontal ligament and gingival fibroblasts from periodontitis patients are more active in interaction with Porphyromonas gingivalis.
    Scheres N; Laine ML; Sipos PM; Bosch-Tijhof CJ; Crielaard W; de Vries TJ; Everts V
    J Periodontal Res; 2011 Aug; 46(4):407-16. PubMed ID: 21332474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation and quantification of key periodontal pathogens in patients with type 2 diabetes.
    Field CA; Gidley MD; Preshaw PM; Jakubovics N
    J Periodontal Res; 2012 Aug; 47(4):470-8. PubMed ID: 22220967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of HLA-DR, DQ and DP antigens and interleukin-2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for "frustrated" activation.
    Pitzalis C; Kingsley G; Lanchbury JS; Murphy J; Panayi GS
    J Rheumatol; 1987 Aug; 14(4):662-6. PubMed ID: 3118018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of Porphyromonas gingivalis and Tannerella forsythensis in periodontally diseased and healthy subjects.
    Yang HW; Huang YF; Chou MY
    J Periodontol; 2004 Aug; 75(8):1077-83. PubMed ID: 15455734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of antigen-presenting cells in human apical periodontitis lesions by flow cytometry and immunocytochemistry.
    Lukić A; Vasilijić S; Majstorović I; Vucević D; Mojsilović S; Gazivoda D; Danilović V; Petrović R; Colić M
    Int Endod J; 2006 Aug; 39(8):626-36. PubMed ID: 16872457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-DQB1 alleles may influence the surface expression of DQ molecules in lymphomononuclear cells of type 1 diabetes mellitus patients.
    Fernandes AP; Foss MC; Donadi EA
    Scand J Immunol; 2004 Mar; 59(3):305-9. PubMed ID: 15030582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen presentation by adherent cells from human peripheral blood. Correlation between T-cell activation and expression of HLA-DQ and -DR antigens.
    Nunez G; Ball EJ; Stastny P
    Hum Immunol; 1987 May; 19(1):29-39. PubMed ID: 3495523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals.
    Naquet P; Ellis J; Tibensky D; Kenshole A; Singh B; Hodges R; Delovitch TL
    J Immunol; 1988 Apr; 140(8):2569-78. PubMed ID: 2451692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.